Prognostic value of positron emission tomography in resected stage IA non-small cell lung cancer

HP Chou, KH Lin, HK Huang, LF Lin, YY Chen… - European …, 2021 - Springer
Objectives To investigate the role of PET in predicting the prognosis of resected stage IA non-
small cell lung cancer (NSCLC) and planning individualized therapeutic strategies. Methods …

Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC

P Borghetti, J Imbrescia, G Volpi, V Scotti… - Radiation …, 2022 - Springer
Background tumor recurrence after NSCLC surgical resection is the most common cause of
treatment failure that sharply reduces the patient's life expectancy. The optimal treatment …

Survival impact of fibrotic interstitial lung abnormalities in resected stage IA non-small cell lung cancer

WG Jeong, YH Kim - The British Journal of Radiology, 2023 - academic.oup.com
Objectives: To assess the association between fibrotic interstitial lung abnormalities (ILAs)
and long-term survival in patients with resected Stage IA non-small cell lung cancer …

[HTML][HTML] Real-world study of disease-free survival & patient characteristics associated with disease-free survival in early-stage non-small cell lung cancer: A …

A Shah, J Apple, AJ Belli, A Barcellos, E Hansen… - Cancer Treatment and …, 2023 - Elsevier
Abstract Introduction/Background Surgical resection remains standard of care for patients
with early-stage non-small cell lung cancer (NSCLC), but research shows that adjuvant …

Relationship between systemic inflammatory markers, GLUT1 expression, and Maximum 18F-Fluorodeoxyglucose Uptake in Non-small Cell Lung Carcinoma and …

SY Park, DG Cho, BY Shim, U Cho - Diagnostics, 2023 - mdpi.com
Background: Factors involved in inflammation and cancer interact in various ways with each
other, and biomarkers of systemic inflammation may have a prognostic value in cancer …

Oncologic outcomes of patients with resected T3N0M0 non-small cell lung cancer

E Marques, KF Kennedy, DJ Giroux, VB Cilento… - Seminars in Thoracic …, 2023 - Elsevier
In the eighth edition TNM staging, the T3N0M0 category represents a heterogeneous group
of non-small cell lung cancers (NSCLC). This study aims to compare the oncologic …

Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma

MC Tai, LE Bantis, G Parhy, T Kato, I Tanaka… - International journal of …, 2024 - mdpi.com
Early-stage lung adenocarcinoma (LUAD) patients remain at substantial risk for recurrence
and disease-related death, highlighting the unmet need of biomarkers for the assessment …

18F-FDG and 68Ga-FAPI PET/CT in the evaluation of ground-glass opacity nodule

H Chen, Y Pang, T Meng, X Yu, L Sun - Clinical Nuclear Medicine, 2021 - journals.lww.com
A 50-year-old woman with a newly detected pulmonary ground-glass opacity (GGO) nodule
underwent PET/CT to determine the likelihood of malignancy. This patient was enrolled in …

USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K

C Prieto‐Garcia, O Hartmann, M Reissland… - Molecular …, 2022 - Wiley Online Library
Oncogenic transformation of lung epithelial cells is a multistep process, frequently starting
with the inactivation of tumour suppressors and subsequent development of activating …

Lung cancer survivors' views on telerehabilitation following curative intent therapy: a formative qualitative study

DM Ha, MA Nunnery, RP Klocko, LM Haverhals… - BMJ open, 2023 - bmjopen.bmj.com
Objectives To inform personalised home-based rehabilitation interventions, we sought to
gain in-depth understanding of lung cancer survivors'(1) attitudes and perceived self-efficacy …